HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIAL

Data Availability

Data and Code Availability The data and codes related to the findings of this study will be available from the corresponding author after publication, upon reasonable request, especially from investigators compiling hydroxychloroquine studies to treat COVID-19. The group formed by the principal investigators will analyze the quality of the proposal and the security offered for the data. The patient-level data, without individual identifiers, will be shared after approval of the submitted proposal.